Managing Treatment-Resistant Depression

Assessment and Switching Medication Approach

The American College of Physicians recommends confirming that the patient has been taking escitalopram 20mg consistently for at least 6-8 weeks to assess adequate response 1
Evaluate for potential causes of worsening symptoms, including medication adherence issues, development of side effects, and emergence of new stressors or comorbid conditions 1
SNRIs like duloxetine have shown slightly better efficacy than SSRIs in patients who did not respond adequately to initial SSRI treatment, according to the American Academy of Family Physicians 2
The American College of Physicians recommends starting duloxetine at 30mg once daily for one week, then increasing to 60mg once daily 1
A 4-week trial at the target dose is recommended to evaluate effectiveness, as suggested by the American College of Physicians 1

The Mayo Clinic suggests that if the patient has significant anxiety symptoms, venlafaxine may be particularly beneficial 4
For patients with comorbid pain symptoms, duloxetine has additional benefits for pain management, according to the Mayo Clinic 4
If sexual dysfunction was a significant issue with escitalopram, bupropion may be considered as it has lower rates of sexual side effects, as noted by the American Academy of Family Physicians 2
The American College of Physicians recommends using lower starting doses and slower titration schedules for elderly patients 1

The American Academy of Family Physicians suggests considering a trial of bupropion, which has a different mechanism of action, if the SNRI switch is unsuccessful 3
Alternatively, consider mirtazapine, particularly if insomnia, poor appetite, or weight loss are issues, as recommended by the American Academy of Family Physicians 3